CompletedNCT05648734

Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis

Studying Idiopathic pulmonary fibrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Mansoura University
Principal Investigator
Amina Abdel Maksoud, MD
Mansoura University, Faculty of Medicine
Intervention
Corticosteroids alone(drug)
Enrollment
200 enrolled
Eligibility
18 years · All sexes
Timeline
20222022

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05648734 on ClinicalTrials.gov

Other trials for Idiopathic pulmonary fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic pulmonary fibrosis

← Back to all trials